Health committee  I'll let you answer that one.

Health committee  But we've made—

Health committee  —we've made progress, in all fairness. There are some remarkable programs that exist now in more specific domains.

Health committee  Not to my knowledge.

Health committee  I think there's definitely been a lot of progress made. Organizations such as CIHI, for instance, have really pushed that to an extent that didn't exist at the time of the accord. Can we do better? Can we go further? I think we could, we can, and we ought to.

Health committee  Well, that's what Infoway is doing, really, but the complexity of our jurisdiction in health care explains why we're not Denmark.

Health committee  We're not Denmark. Denmark has full implementation of health records.

Health committee  I would agree with that.

Health committee  First of all, I would comment on funding. We're spending $170 billion a year on health care in this country. CIHR's budget is $1 billion. Now, just think of what successful company invests that percentage of their budget in R and D. That's just a question. We want the system to

Health committee  It's true of the research agenda. Let's face it. The research agenda to a large extent is one that has been a researcher agenda. I think we have to bring in the decision-makers, the policy-makers, the patients, and involve them in defining the research agenda.

Health committee  It's an excellent and also a difficult question because we haven't done enough. One of the reasons we haven't done enough is that it's expensive to do what you're talking about. There's an excellent report from the Canadian Academy of Health Sciences on measuring impacts of hea

Health committee  We don't have them in Canada, but I recommend that you refer to a report of the Institute of Medicine in the U.S., which was published three weeks ago. It produced a very important and interesting analysis of the waste in the U.S. health care system. Although we have to be carefu

Health committee  There are two things. First is more money, as always. Let's face it. We're talking about having to support that research. I think it's great to see that the provinces are willing to invest with us in this area, that they recognize the importance of a better evaluation, and a co

Health committee  This is correct. The patient-oriented research strategy is really a joint initiative. It brings together all the stakeholders. We're all facing the same issues. It brings together the provinces, the territories, the federal government, but also stakeholders from the private secto

Health committee  There are really two aspects to this. First of all, we not only have to introduce these new emerging technologies when they work— and they've been properly assessed and shown to work significantly and to be cost-effective—but we also have to develop a culture whereby we stop doin